Reproductive factors and the risk of endometrial cancer

International Journal of Gynecological Cancer

Volumn 24, Issue 3, 2014, Pages 384-393

  Ali, Aus Tariq ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Early menarche; Endometrial cancer; Late menopause; Null parity

Indexed keywords

ANASTROZOLE; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; ESTROGEN; FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LETROZOLE; LUTEINIZING HORMONE; METFORMIN; ORAL CONTRACEPTIVE AGENT; PIOGLITAZONE; PROGESTERONE; RALOXIFENE; ROSIGLITAZONE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

ABORTION; ANOVULATION; BLOOD CLOTTING; BREAST CANCER; CANCER RISK; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG CHOICE; ENDOMETRIAL THICKNESS; ENDOMETRIUM; ENDOMETRIUM CANCER; ESTROGEN ACTIVITY; ESTROGEN METABOLISM; ESTROGEN RESPONSIVE ELEMENT; ESTROGEN SYNTHESIS; ESTROGEN THERAPY; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; HORMONE SUBSTITUTION; HUMAN; INFERTILITY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LACTATION; LIPID METABOLISM; LIPID STORAGE; LIVE BIRTH; MENARCHE; MENOPAUSE; MITOSIS RATE; NULLIPARA; OBESITY; OVARY POLYCYSTIC DISEASE; OVULATION; OVULATION INDUCTION; PARITY; POSTMENOPAUSE; PREGNANCY; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; REPRODUCTION; REVIEW; SPONTANEOUS ABORTION; THIRD TRIMESTER PREGNANCY; TRANSCRIPTION INITIATION; VAGINAL DELIVERY; WEIGHT GAIN; WEIGHT REDUCTION; ADENOCARCINOMA; ENDOMETRIAL NEOPLASMS; FEMALE; REPRODUCTIVE HISTORY; RISK FACTOR;

ADENOCARCINOMA; ENDOMETRIAL NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; FERTILIZATION IN VITRO; HUMANS; OVULATION INDUCTION; REPRODUCTIVE HISTORY; RISK FACTORS; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 84900387268     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000075     Document Type: Review

References (35)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96.
2. Buchanan EM, Weinstein LC, Hillson C. Endometrial cancer. Am Fam Physician. 2009;80:1075-1080.
3. Duong LM, Wilson RJ, Ajani UA, et al. Trends in endometrial cancer incidence rates in the United States, 1999-2006. J Womens Health (Larchmt). 2011;20:1157-1163.
4. Slyper AH. The pubertal timing controversy in the USA, and a review of possible causative factors for the advance in timing of onset of puberty. Clin Endocrinol (Oxf ). 2006;65:1-8.
5. Saltzman BS, Doherty JA, Hill DA, et al. Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors. Am J Epidemiol. 2008;167:607-614.
6. Fujita M, Tase T, Kakugawa Y, et al. Smoking, earlier menarche and low parity as independent risk factors for gynecologic cancers in Japanese: a case-control study. Tohoku J Exp Med. 2008;216:297-307.
7. Reis N, Beji NK. Risk factors for endometrial cancer in Turkish women: results from a hospital-based case-control study. Eur J Oncol Nurs. 2009;13:122-127.
8. Brinton LA, Berman ML, Mortel R, et al. Reproductive, menstrual, and medical risk factors for endometrial cancer: results froma case-control study. AmJ Obstet Gynecol. 1992;167: 1317-1325.
9. Setiawan VW, Pike MC, Kolonel LN, et al. Racial/ethnic differences in endometrial cancer risk: the multiethnic cohort study. Am J Epidemiol. 2007;165:262-270.
10. Wernli KJ, Ray RM, Gao DL, et al. Menstrual and reproductive factors in relation to risk of endometrial cancer in Chinese women. Cancer Causes Control. 2006;17:949-955.
11. Zucchetto A, Serraino D, Polesel J, et al. Hormone-related factors and gynecological conditions in relation to endometrial cancer risk. Eur J Cancer Prev. 2009;18:316-321.
12. Brinton LA, Westhoff CL, Scoccia B, et al. Causes of infertility as predictors of subsequent cancer risk. Epidemiology. 2005;16: 500-507.
13. Uharcek P, Mlyncek M, Ravinger J, et al. Prognostic factors in women 45 years of age or younger with endometrial cancer. Int J Gynecol Cancer. 2008;18:324-328.
14. Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002;94:606-616.
15. Lacey JV Jr, Brinton LA, Lubin JH, et al. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2005;14: 1724-1731.
16. Weiderpass E, Adami HO, Baron JA, et al. Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst. 1999;91:1131-1137.
17. Doherty JA, Cushing-Haugen KL, Saltzman BS, et al. Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer. Am J Obstet Gynecol. 2007;197:139.e1-139.e7.
18. Razavi P, Pike MC, Horn-Ross PL, et al. Long-term postmenopausal hormone therapy and endometrial cancer. Cancer Epidemiol Biomarkers Prev. 2010;19:475-483.
19. Weiderpass E, Adami HO, Baron JA, et al. Use of oral contraceptives and endometrial cancer risk (Sweden). Cancer Causes Control. 1999;4:277-284.
20. Parslov M, Lidegaard O, Klintorp S, et al. Risk factors among young women with endometrial cancer: a Danish case-control study. Am J Obstet Gynecol. 2000;182:23-29.
21. Voigt LF, Deng Q, Weiss NS. Recency, duration, and progestin content of oral contraceptives in relation to the incidence of endometrial cancer (Washington, USA). Cancer Causes Control. 1994;5:227-233.
22. Pfeiffer RM, Mitani A, Landgren O, et al. Timing of births and endometrial cancer risk in Swedish women. Cancer Causes Control. 2009;20:1441-1449.
23. Brinton LA, Sakoda LC, Lissowska J, et al. Reproductive risk factors for endometrial cancer among Polish women. Br J Cancer. 2007;96:1450-1456.
24. Dossus L, Allen N, Kaaks R, et al. Reproductive risk factors and endometrial cancer: the European prospective investigation into cancer and nutrition. Int J Cancer. 2010;127:442-451.
25. Kalandidi A, Tzonou A, Lipworth L, et al. A case-control study of endometrial cancer in relation to reproductive, somatometric, and life-style variables. Oncology. 1996;53:354-359.
26. Weiss NS, Farewall VT, Szekely DR, et al. Oestrogens and endometrial cancer: effect of other risk factors on the association. Maturitas. 1980;2:185-190.
27. McPherson CP, Sellers TA, Potter JD, et al. Reproductive factors and risk of endometrial cancer. The IowaWomen's Health Study. Am J Epidemiol. 1996;143:1195-1202.
28. Xu WH, Xiang YB, Ruan ZX, et al. Menstrual and reproductive factors and endometrial cancer risk: results from a population-based case-control study in urban Shanghai. Int J Cancer. 2004;108:613-619.
29. Källén B, Finnström O, Lindam A, et al. Malignancies among women who gave birth after in vitro fertilization. Hum Reprod. 2011;26:253-258.
30. Lerner-Geva L, Rabinovici J, Olmer L, et al. Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up. Gynecol Endocrinol. 2012;28:809-814.
31. Yli-Kuha AN, Gissler M, Klemetti R, et al. Cancer morbidity in a cohort of 9175 Finnish women treated for infertility. Hum Reprod. 2012;27:1149-1155.
32. Jensen A, Sharif H, Olsen JH, et al. Risk of breast cancer and gynecologic cancers in a large population of nearly 50, 000 infertile Danish women. Am J Epidemiol. 2007;16:1400-1407.
33. Siristatidis C, Sergentanis TN, Kanavidis P, et al. Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancerVa systematic review and meta-analysis. Hum Reprod Update. 2013;19:105-123.
34. Brinton LA, Trabert B, Shalev V, et al. In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services. Fertil Steril. 2013;99:1189-1196.
35. Jabbour HN, Kelly RW, Fraser HM, et al. Endocrine regulation of menstruation. Endocr Rev. 2006;27:17-46.